Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hanus

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Social Science & Medicine (1982)|September 20, 2024
Racial discrimination predicts subjective cognitive decline: Perceived relationship support buffers the associationMan-Kit Lei, Stephanie L Hanus, Leslie G Simons, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|June 29, 2013
[Adaptive phenomenon of ischemic postconditioning of the heart. Perspectives of clinical use]L N Maslov, A G Mrochek, I G Khaliulin, et al.
Nature|September 4, 1997
Anandamide may mediate sleep inductionR Mechoulam, E Fride, L Hanus, et al.
Journal of Medicinal Chemistry|November 5, 1997
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclaseM H Rhee, Z Vogel, J Barg, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptorL Hanus, S Abu-Lafi, E Fride, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|November 20, 2012
[Phenomenon of heart ischemic postconditioning]L N Maslov, A G Mrochek, L Hanus, et al.
European Journal of Pharmacology|December 12, 1995
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamidesJ Barg, E Fride, L Hanus, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 18, 2012
[Perspective of creation of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion]L N Maslov, Iu B Lishmanov, J P Headrick, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 18, 2013
[Signaling mechanism of cardioprotective effects of opioids]L N Maslov, L Hanus, J -M Pei, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1999
HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptorL Hanus, A Breuer, S Tchilibon, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Social Science & Medicine (1982)|September 20, 2024
Racial discrimination predicts subjective cognitive decline: Perceived relationship support buffers the associationMan-Kit Lei, Stephanie L Hanus, Leslie G Simons, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|June 29, 2013
[Adaptive phenomenon of ischemic postconditioning of the heart. Perspectives of clinical use]L N Maslov, A G Mrochek, I G Khaliulin, et al.
Nature|September 4, 1997
Anandamide may mediate sleep inductionR Mechoulam, E Fride, L Hanus, et al.
Journal of Medicinal Chemistry|November 5, 1997
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclaseM H Rhee, Z Vogel, J Barg, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptorL Hanus, S Abu-Lafi, E Fride, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|November 20, 2012
[Phenomenon of heart ischemic postconditioning]L N Maslov, A G Mrochek, L Hanus, et al.
European Journal of Pharmacology|December 12, 1995
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamidesJ Barg, E Fride, L Hanus, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 18, 2012
[Perspective of creation of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion]L N Maslov, Iu B Lishmanov, J P Headrick, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 18, 2013
[Signaling mechanism of cardioprotective effects of opioids]L N Maslov, L Hanus, J -M Pei, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1999
HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptorL Hanus, A Breuer, S Tchilibon, et al.
Pageof 5